These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 224603)

  • 1. [Does the concept for the prevention of chronic ischemic heart disease correspond to current ideas on etiology and pathogenesis of arteriosclerosis?].
    Hecht A
    Z Gesamte Inn Med; 1979 Jun; 34(11):297-301. PubMed ID: 224603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 3. Cholesterol and atherosclerosis-fact or fiction?
    Nash DT
    Geriatrics; 1981 Jan; 36(1):128-32. PubMed ID: 7450502
    [No Abstract]   [Full Text] [Related]  

  • 4. Stenoses in the coronary arteries. Relation to atherosclerotic lesions, coronary heart disease, and risk factors. The Oslo Study.
    Solberg LA; Strong JP; Holme I; Helgeland A; Hjermann I; Leren P; Mogensen SB
    Lab Invest; 1985 Dec; 53(6):648-55. PubMed ID: 4068669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers, plasma lipids, and coronary heart disease.
    Cruickshank JM
    Circulation; 1990 Sep; 82(3 Suppl):II60-5. PubMed ID: 1975524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension.
    Bühler FR; Tkachuk VA; Hahn AW; Resink TJ
    J Hypertens Suppl; 1991 Dec; 9(6):S28-36. PubMed ID: 1818968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Introduction to current problems in arteriosclerosis research].
    Hecht A
    Z Gesamte Inn Med; 1986 Jul; 41(14):385-7. PubMed ID: 3765738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic considerations.
    Miller NE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S190-5. PubMed ID: 6177955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory parameters as discriminators for peripheral atherosclerosis and stroke.
    Kostner GM; Marth E; Pfeiffer KH; Wege H
    Monogr Atheroscler; 1986; 14():119-23. PubMed ID: 3736549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Can the moderate use of alcohol be considered a protective factor against ischemic cardiopathy?].
    Lombardi C; Rusconi C; Panteghini M
    Minerva Cardioangiol; 1984 Oct; 32(10):647-52. PubMed ID: 6527799
    [No Abstract]   [Full Text] [Related]  

  • 11. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 12. Lipoproteins and coronary heart disease.
    Krauss RM
    Postgrad Med; 1989 Apr; Spec No():54-8; discussion 89-90. PubMed ID: 2726627
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum lipoproteins in patients with clinical signs of atherosclerosis: peripheral vascular and coronary heart disease.
    Kaliman J; Widhalm K; Strobl W
    Artery; 1980; 8(6):547-52. PubMed ID: 7259533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of antiatherosclerosis diet with different total caloric value on the level of high density lipoproteins cholesterol in patients with ischemic heart disease].
    Samsonov MA; Frolova IA; Paramonova EG; Zubenko AD; Sirota II
    Vopr Pitan; 1981; (5):15-20. PubMed ID: 7314609
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of cholesterol in high-density lipoproteins in determining risk for atherosclerosis].
    Brücknerová O
    Vnitr Lek; 1982 Jan; 28(1):15-22. PubMed ID: 7058632
    [No Abstract]   [Full Text] [Related]  

  • 17. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherosclerosis of retinal arteries in men: role of serum lipoproteins and apoproteins.
    Tedeschi-Reiner E; Reiner Z; Sonicki Z
    Croat Med J; 2004 Jun; 45(3):333-7. PubMed ID: 15185429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HDL--the unknown with great significance].
    Mordasini R; Riesen W; Oster P
    Schweiz Med Wochenschr; 1981 Feb; 111(9):309-14. PubMed ID: 7221532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].
    De Caterina R; Lenzi S
    G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.